About: Inflammatory bowel disease

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Inflammatory bowel disease Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	Concept
rdfs:label	Inflammatory bowel disease
skos:inScheme	http://hub.abes.fr/referentiel/bmjarticlecategories
is Subject of	Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study Detrimental role for CD4+ T lymphocytes in murine diffuse peritonitis due to inhibition of local bacterial elimination Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy Flt3 ligand expands CD103+ dendritic cells and FoxP3+ T regulatory cells, and attenuates Crohn's-like murine ileitis Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol Increased mucosal tumour necrosis factor α production in Crohn’s disease can be downregulated ex vivo by probiotic bacteria NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease Expression of NOD2 in Paneth cells: a possible link to Crohn’s ileitis Insurance problems among inflammatory bowel disease patients: results of a Dutch population based study Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid Treatment of active Crohn’s disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk? PTU-059 Adalimumab Therapy Reduces Hospitalization and Colectomy Rates in Patients with Ulcerative Colitis among Initial Responders PWE-076 Dendritic Cell Characteristics in Pouchitis PWE-102 The use of TPMT Enzyme Testing in Managing Thiopurine Therapy PWE-088 Abnormal Liver Function Tests Following use of Thiopurines in a Large Cohort of Inflammatory Bowel Disease Patients-Do TPMT Levels Matter? PTU-073 Dose Intensification with Anti-TNF Agents in Inflammatory Bowel Disease- a Secondary Care Experience Extracellular cathepsin K exerts antimicrobial activity and is protective against chronic intestinal inflammation in mice Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study The intermediate filament protein, vimentin, is a regulator of NOD2 activity PTH-090 Efficacy and Safety of Double-Dosing or Decreasing the Interval of Anti-Tnf Therapy in Crohn’S Disease who have Shown Loss of Response to Standard Anti-Tnf Dosing Regimen - A Dgh Experience PTH-087 Fam5C, a Possible Causal Molecule in Ulcerative Colitis Revealed through a Transcriptomic Analysis of the Bowel Mucosa PTH-112 Infliximab Promotes Steroid free Remission in Patients with Chronic Active Ulcerative Colitis- a UK Single Centre Experience Energy expenditure and body composition in children with Crohn’s disease: effect of enteral nutrition and treatment with prednisolone Role of bile acids and bile acid binding agents in patients with collagenous colitis Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide Serological markers predict inflammatory bowel disease years before the diagnosis Increased expression of interleukin 17 in inflammatory bowel disease Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Incidence and prevalence of ulcerative colitis in Punjab, North India Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn’s disease T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn’s disease In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4+CD62L+ T cells which prevent intestinal inflammation in the SCID transfer model of colitis The role of eosinophils in inflammatory bowel disease Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells PWE-096 Is there an Association Between Parkinson’S Disease and Inflammatory Bowel Disease ? PTH-091 To Evaluate the Efficacy and Safety of 6-Thioguanine Therapy in Patients with Inflammatory Bowel Disease - a DGH Experience PTU-070 Selecting the most Cost-Effective Model of Care for Delivering Biological Agents as Maintenance Therapy in Patients with Crohn’S Disease PTH-100 Psychological Morbidity and Provision of Psychological Support in the Inflammatory Bowel Disease Clinic PTH-084 Endoscopic and Histological Activity as Predictors of Relapse in Patients Undergoing Surveillance Colonoscopy for Ulcerative Colitis Anticipation in familial Crohn’s disease Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis Long-term outcome of treatment with infliximab in 614 patients with Crohn’s disease: results from a single-centre cohort Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis Diagnostic accuracy of magnetic resonance colonography for the evaluation of disease activity and severity in ulcerative colitis: a prospective study Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation mTNF reverse signalling induced by TNFα antagonists involves a GDF-1 dependent pathway: implications for Crohn's disease Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn’s disease Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor Probiotics in inflammatory bowel disease: is it all gut flora modulation? DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn’s disease Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis Dynamics of mucosal permeability and inflammation in collagenous colitis before, during, and after loop ileostomy Osteopontin/Eta-1 upregulated in Crohn’s disease regulates the Th1 immune response Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 Infliximab and newly diagnosed neoplasia in Crohn’s disease: a multicentre matched pair study Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial Phenotype at diagnosis predicts recurrence rates in Crohn’s disease PWE-100 How Commonly Does Faecal Calprotectin Alter Management in Patients with I.B.D? PTH-096 Oral Ciclopsorin in Steroid Refractory, Acute, Severe Ulcerative Colitis PTH-113 Clinical Response to Induction Anti-Tnf Therapy has no Effect on Haemoglobin Levels in Patients with IBD PTH-106 Unravelling the Mechanism of Action of Infliximab in Crohn’S Disease and Healthy Controls Following in Vitro Culture with Blood-Enriched Dendritic Cells PWE-090 Outcomes of Patients with Ulcerative Colitis who are Azathioprine Tolerant and Azathioprine Intolerant PTH-115 Outcome of Ulcerative Colitis Patients that have Failed Conventional Thiopurine Therapy; Allopurinol Co-Therapy and Beyond PTU-060 Phenotypic Characterisation of Inflammatory Bowel Disease in South Asians in the United Kingdom-Insights into a Shifting Landscape PWE-075 Association between Thiopurine use and Non-Melanoma Skin Cancers in Patients with Inflammatory Bowel Disease: A Meta-Analysis PWE-110 Acceptance and Adjustment in a District General Cohort of Inflammatory Bowel Disease Patients: Findings and Implications PTH-085 Monoclonal Antibody Therapy in Crohn’S Disease: Does Serial Faecal Calprotectin Play a Role? Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn’s disease Reduced α-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn’s disease Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial Role of alkaline phosphatase in colitis in man and rats

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata